Cronos Australia Ltd. (AU:VIT)
ASX:VIT
Want to see AU:VIT full AI Analyst Report?
VIT Stock Chart & Stats
AU$0.06
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.06
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.03 - AU$0.08
Previous CloseN/A
Volume1.00K
Average Volume (3M)228.84K
Market Cap
AU$19.22M
Enterprise ValueAU$31.12M
Total Cash (Recent Filing)AU$6.10M
Total Debt (Recent Filing)AU$17.34M
Price to Earnings (P/E)20.0
Beta1.52
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.28%
Share Statistics
EPS (TTM)<0.01
Shares Outstanding662,741,800
10 Day Avg. Volume238,134
30 Day Avg. Volume228,844
Financial Highlights & Ratios
PEG Ratio-1.00
Price to Book (P/B)0.78
Price to Sales (P/S)0.30
P/FCF Ratio14.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage & Strong Equity BaseLow leverage and a strong equity base give the company durable financial flexibility: with debt-to-equity 0.25 and equity ratio 63.85% it can fund operations, absorb regulatory or cultivation cycle shocks, pursue selective capex/partnerships and avoid refinancing stress over months.
Stable Gross Profit MarginA stable gross profit margin of 27.21% signals persistent cost control or favorable product mix. This margin provides a structural buffer to absorb pricing pressure or input cost swings in the cannabis supply chain, helping maintain unit economics while revenue growth is addressed.
High FCF-to-net-income ConversionFree cash flow converts nearly all reported net income into cash (FCF/net income 0.97), indicating earnings are largely cash-backed. Over the medium term this supports dividend sustainability, working capital needs and targeted reinvestment despite episodic FCF growth volatility.
Bears Say
Severe FCF Growth DeclineA massive FCF growth drop of -2056.03% is a red flag for cash generation durability. Such a decline constrains funding for capex, inventory and growth initiatives, increases reliance on external financing, and exposes the business to liquidity stress across a 2–6 month horizon.
Weak Operating Cash ConversionOCF to net income at 0.14 implies weak cash conversion and potential earnings quality issues: heavy non-cash items or working capital drains. Low OCF conversion undermines free cash flow consistency essential for dividends, capex, and debt servicing over the medium term.
Low Margins And Soft Revenue TrendNegative recent revenue growth (-2.001%) combined with a slim net margin of 2.68% and low EBIT/EBITDA margins indicates limited operational leverage. That reduces ability to scale, invest in differentiation, and withstand pricing or regulatory headwinds in a competitive cannabis market.
Cronos Australia Ltd. News
VIT FAQ
What was Cronos Australia Ltd.’s price range in the past 12 months?
Cronos Australia Ltd. lowest share price was AU$0.03 and its highest was AU$0.07 in the past 12 months.
What is Cronos Australia Ltd.’s market cap?
Cronos Australia Ltd.’s market cap is AU$19.22M.
When is Cronos Australia Ltd.’s upcoming earnings report date?
Cronos Australia Ltd.’s upcoming earnings report date is Aug 26, 2026 which is in 63 days.
How were Cronos Australia Ltd.’s earnings last quarter?
Cronos Australia Ltd. released its earnings results on Feb 25, 2026. The company reported -AU$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.001.
Is Cronos Australia Ltd. overvalued?
According to Wall Street analysts Cronos Australia Ltd.’s price is currently Overvalued.
Does Cronos Australia Ltd. pay dividends?
Cronos Australia Ltd. pays a Annually dividend of AU$0.002 which represents an annual dividend yield of 3.28%. See more information on Cronos Australia Ltd. dividends here
What is Cronos Australia Ltd.’s EPS estimate?
Cronos Australia Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cronos Australia Ltd. have?
Cronos Australia Ltd. has 662,741,800 shares outstanding.
What happened to Cronos Australia Ltd.’s price movement after its last earnings report?
Cronos Australia Ltd. reported an EPS of -AU$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.167%.
Which hedge fund is a major shareholder of Cronos Australia Ltd.?
Currently, no hedge funds are holding shares in AU:VIT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cronos Australia Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.51%
12-Months-Change
Fundamentals
Return on Equity
1.66%
Trailing 12-Months
Asset Growth
8.56%
Trailing 12-Months
Company Description
Cronos Australia Ltd.
Established in 2018 and based in South Yarra, Australia, Vitura Health Limited focuses on the supply and marketing of medicinal cannabis goods throughout Australia and the Asian market. The company manages a portfolio of key brands, such as CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. This entity was formerly recognized as Cronos Australia Limited before adopting the name Vitura Health Limited in February 2023.
Technical Analysis
Elixinol Wellness
―
Cann Group
―
Epsilon Healthcare Limited
―
Little Green Pharma Ltd.
―
―